Allergan

Latest stories

4h
Business Wire
ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive OfficerSAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a bioph
ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer
Business Wire / Posted 4 hours ago
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today... Read more
6h
Swissinfo
Santen Considers Takeovers as CEO Seeks Expansion Outside Japan(Bloomberg) -- Santen Pharmaceutical Co. has its eye on acquisitions. The Japa
Santen Considers Takeovers as CEO Seeks Expansion Outside Japan
Swissinfo / Posted 6 hours ago
(Bloomberg) -- Santen Pharmaceutical Co. has its eye on acquisitions. The Japanese maker of eye-care products, which opened an office in Geneva this month as part of a push outside its home market, is counting on a mix of takeovers and innovation to... Read more
17h
Channel NewsAsia
Ackman's Pershing Square hedge fund drops 9.2 percent in AugustBOSTON: Billionaire investor William Ackman, one of last year's best performing
Ackman's Pershing Square hedge fund drops 9.2 percent in August
Channel NewsAsia / Posted 17 hours ago
BOSTON: Billionaire investor William Ackman, one of last year's best performing hedge fund managers, saw his Pershing Square Holdings portfolio drop 9.2 percent in August as some of its major holdings joined a broad market slump, a source familiar... Read more
21h
Investopedia
Direxion Daily Healthcare Bull 3X (CUREThe Direxion Daily Healthcare Bull 3x (NYSEARCA: CURE) was introduced in June 2
Direxion Daily Healthcare Bull 3X (CURE
Investopedia / Posted 21 hours ago
The Direxion Daily Healthcare Bull 3x (NYSEARCA: CURE) was introduced in June 2011. Direxion is a pioneer in introducing leveraged exchange-traded fund (ETF) products for active investors who are looking for increased volatility. CURE has become one... Read more
23h
Investopedia
The 3 Best Investments Bill Ackman Ever Made (GGP,CP,VRX)The three best investments made by Bill Ackman are General Growth Properties, I
The 3 Best Investments Bill Ackman Ever Made (GGP,CP,VRX)
Investopedia / Posted 23 hours ago
The three best investments made by Bill Ackman are General Growth Properties, Inc. (NYSE: GGP), Canadian Pacific Railway, Ltd. (NYSE: CP) and Valeant Pharmaceuticals, Inc. (NYSE: VRX). All of these investments were substantial in size and as a... Read more
1d
News-Medical-Net
FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)Allergan plc (NYSE: AGN) today announced the U.S. Food and Drug Administration
FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)
News-Medical-Net / Posted yesterday
Allergan plc (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental new drug application (sNDA) to update the label for TEFLARO® (ceftaroline fosamil) for the treatment of adult patients with... Read more
1d
News-Medical-Net
Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTIAllergan plc. (NYSE: AGN) today announced positive topline results from RECAPTU
Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI
News-Medical-Net / Posted yesterday
Allergan plc. (NYSE: AGN) today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ™ (ceftazidime-avibactam) as a treatment for adult hospitalized patients with complicated urinary... Read more
2d
TheStreet.com
Oppenheimer's 10 Stocks to 'Buy on Weakness'NEW YORK (TheStreet) -- Is the current market volatility a trader's paradise? O
Oppenheimer's 10 Stocks to 'Buy on Weakness'
TheStreet.com / Posted 2 days ago
NEW YORK (TheStreet) -- Is the current market volatility a trader's paradise? Oppenheimer seems to think so. "The uptick in volatility has stressed the need to be tactical, in our view, and traders should therefore be eyeing mean-reverting... Read more
32 related stories
2d
Morningstar
Ultimate Stock-Pickers' Top 10 Buys and SellsThe last genuine correction we had before this one (in which the S&P 500 droppe
Ultimate Stock-Pickers' Top 10 Buys and Sells
Morningstar / Posted 2 days ago
The last genuine correction we had before this one (in which the S&P 500 dropped from 2,102 on Aug. 18 to 1,868 on Aug. 25) was during April-June 2012, when the markets pulled back 10% in response to concerns about corporate earnings, the Federal... Read more
3d
Business Wire
Prescription Pain Drugs: Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana -2020 Analysis and ForecastsDUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.co
Prescription Pain Drugs: Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana -2020 Analysis and Forecasts
Business Wire / Posted 3 days ago
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5hvt25/prescription_pain) has announced the addition of the "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/... Read more
5d
Calcutta News
Takeover bid for Perrigo wins majority support of Mylan shareholders PITTSBURGH - Shareholders of Mylan N.V., a global pharmaceutical company, Fri
Takeover bid for Perrigo wins majority support of Mylan shareholders
Calcutta News / Posted 5 days ago
PITTSBURGH - Shareholders of Mylan N.V., a global pharmaceutical company, Friday overwhelmingly approved the company's $35.6 billion bid for Perrigo Company plc, giving a fillip to... Read more
16 related stories
6d
The Charleston State Journal
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
The Charleston State Journal / Posted 6 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
Park Record
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Park Record / Posted 6 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
The Evening Sun
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
The Evening Sun / Posted 6 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
New Jersey Herald
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
New Jersey Herald / Posted 6 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
York Daily Record
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
York Daily Record / Posted 6 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
Your Hometown Lima Stations
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Your Hometown Lima Stations / Posted 6 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
Carlsbad Current-Argus
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Carlsbad Current-Argus / Posted 6 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
KOB 4 Albuquerque
Mylan shareholders approve pursuit of PerrigoCreated: 08/28/2015 6:21 AM NEW YORK (AP) — Mylan NV's shareholders approved t
Mylan shareholders approve pursuit of Perrigo
KOB 4 Albuquerque / Posted 6 days ago
Created: 08/28/2015 6:21 AM NEW YORK (AP) — Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted... Read more
16 related stories
6d
Lebanon Daily News
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Lebanon Daily News / Posted 6 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
6d
Daily Herald
Mylan shareholders approve pursuit of PerrigoNEW YORK -- Mylan NV's shareholders approved the proposed buyout of Perrigo Co.
Mylan shareholders approve pursuit of Perrigo
Daily Herald / Posted 6 days ago
NEW YORK -- Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures from Mylan. A... Read more
16 related stories
6d
ABC News
Mylan Shareholders Approve Pursuit of PerrigoMylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. a
Mylan Shareholders Approve Pursuit of Perrigo
ABC News / Posted 6 days ago
Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures from Mylan. In a... Read more
16 related stories
6d
Fast Company Magazine
Why Women Are Turning To "Blowtox" Injections To Preserve Their HairdosJeannel Astarita has long, thick hair that gets frizzy when she sweats. It take
Why Women Are Turning To "Blowtox" Injections To Preserve Their Hairdos
Fast Company Magazine / Posted 6 days ago
Jeannel Astarita has long, thick hair that gets frizzy when she sweats. It takes her 40 minutes to blow dry it and another 20 minutes to curl it, and she'll go to great lengths to avoid this routine. That used to mean skipping workouts after work and... Read more
7d
TheStreet.com
Allergan's Stock Chart Is Flashing a Buy SignalShares of the pharmaceuticals company, which makes Botox and other specialty dr
Allergan's Stock Chart Is Flashing a Buy Signal
TheStreet.com / Posted 7 days ago
Shares of the pharmaceuticals company, which makes Botox and other specialty drugs, have managed to hold above their 200-day moving average during this current period of extreme volatility. The low yesterday bounced off the average, forming a bullish... Read more
7d
Business Insider
Bill Ackman's gains for the year got wiped out in a matter of weeks"However there has been significant volatility in the investment markets over t
Bill Ackman's gains for the year got wiped out in a matter of weeks
Business Insider / Posted 7 days ago
"However there has been significant volatility in the investment markets over the past few weeks, largely driven by the decline of the Chinese stock markets, and the fear that slowing growth in China will have repercussions for businesses around the... Read more
7d
WAND TV 17 Decatur
Eye Ointment RecallWASHINGTON - Allergan is voluntarily recalling certain lots of various eye oint
Eye Ointment Recall
WAND TV 17 Decatur / Posted 7 days ago
WASHINGTON - Allergan is voluntarily recalling certain lots of various eye ointments, because some users reported them to be contaminated, the pharmaceutical company announced. A small number of customers found a small black particle attached to the... Read more
7d
Business Wire
Blue Skies, LLC Launches Digital Enterprise Consulting ServicesLOS ANGELES--(BUSINESS WIRE)--Blue Skies, LLC, a management consulting firm bas
Blue Skies, LLC Launches Digital Enterprise Consulting Services
Business Wire / Posted 7 days ago
LOS ANGELES--(BUSINESS WIRE)--Blue Skies, LLC, a management consulting firm based in Southern California, announced today that it has adopted a new service model in order to serve clients who must compete in an increasingly digital economy. “Today... Read more
8d
Morningstar
High-Quality Stocks on SaleMarket volatility may hang around, at least for a while. As Morningstar.com sit
High-Quality Stocks on Sale
Morningstar / Posted 8 days ago
Market volatility may hang around, at least for a while. As Morningstar.com site editor Jason Stipp has noted, worries about China, global growth, and the timing of interest-rate moves by the Fed may keep investors on edge over the short term.... Read more
8d
KMGH 7 Denver
Allergan recalls specific lots of eye drops nationwide, says lots contain particular matterDENVER - Several products from Allergan plc's line of eye drops are being recal
Allergan recalls specific lots of eye drops nationwide, says lots contain particular matter
KMGH 7 Denver / Posted 8 days ago
DENVER - Several products from Allergan plc's line of eye drops are being recalled Tuesday, a spokesman for the Colorado Department of Health and Environment told 7NEWS. The recall was placed after specific lots of eye drops were found to contain... Read more
8d
Business Wire
Dr. George Lasezkay Joins Acucela as Executive Vice President, Legal AffairsSEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company
Dr. George Lasezkay Joins Acucela as Executive Vice President, Legal Affairs
Business Wire / Posted 8 days ago
SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of... Read more
8d
Zero Hedge
Hedge Fund Hotel California: Smart Money Darlings Crash Up To 42% In One WeekLate last week, we reported that as of mid-August hedge funds are set to record
Hedge Fund Hotel California: Smart Money Darlings Crash Up To 42% In One Week
Zero Hedge / Posted 8 days ago
Late last week, we reported that as of mid-August hedge funds are set to record their seventh consecutive years of market underperformance (unless the S&P crashes into year end, the Fed does not lose control, and hedge funds actually end up being... Read more
8d
TheStreet.com
Put Impax, Akorn and Sagent on Your Watch List of Generics TargetsNEW YORK (The Deal) -- Generics companies have been so enthusiastic about buyin
Put Impax, Akorn and Sagent on Your Watch List of Generics Targets
TheStreet.com / Posted 8 days ago
NEW YORK (The Deal) -- Generics companies have been so enthusiastic about buying each other over the past several years that they are running out of targets. As a result, specialty pharmaceutical companies are now in the M&A spotlight as acquisitive... Read more
9d
Investopedia
Healthcare M&A and Prescription Drug PricesIn 2015, there has been a high level of mergers and acquisition (M&A) activity
Healthcare M&A and Prescription Drug Prices
Investopedia / Posted 9 days ago
In 2015, there has been a high level of mergers and acquisition (M&A) activity in the health care sector among both health insurers and drug companies. Many consumers are wondering what effect these mergers will have on their health care plans and... Read more
9d
NJ Biz
Valeant doubles office space in Bridgewater, to 620K sq. ft.Valeant Pharmaceuticals International Inc. has leased another 310,000 square fe
Valeant doubles office space in Bridgewater, to 620K sq. ft.
NJ Biz / Posted 9 days ago
Valeant Pharmaceuticals International Inc. has leased another 310,000 square feet at Somerset Corporate Center in Bridgewater, doubling its footprint at the SJP Properties-owned complex less than two years after establishing its U.S. headquarters... Read more
11d
Business Insider
Hedge funds are shaking up corporate America and Wall Street couldn't be happierHedge fund managers that agitate for changes at public companies, asking for ev
Hedge funds are shaking up corporate America and Wall Street couldn't be happier
Business Insider / Posted 11 days ago
Hedge fund managers that agitate for changes at public companies, asking for everything from bigger dividends to outright sales, have grown their war chests, been taking on more targets, and had larger victories than ever. They have successfully... Read more
12d
Business Standard India
Maker of Addyi, 'female Viagra' drug, being sold to Valeant for $1 bnThe FDA had rejected the drug twice before finally approving it on TuesdayThe F
Maker of Addyi, 'female Viagra' drug, being sold to Valeant for $1 bn
Business Standard India / Posted 12 days ago
The FDA had rejected the drug twice before finally approving it on TuesdayThe FDA had rejected the drug twice before finally approving it on Tuesday Sprout Pharmaceuticals, which on... Read more
686 related stories
13d
Investopedia
10 Overlooked Growth Stocks to Consider (ADBE,UA,NFLX)It’s difficult to find high-potential opportunities in the current market envir
10 Overlooked Growth Stocks to Consider (ADBE,UA,NFLX)
Investopedia / Posted 13 days ago
It’s difficult to find high-potential opportunities in the current market environment, but it’s not impossible. Prior to moving on and revealing these potential opportunities, there are a couple of things to note. Since we’re heading for a... Read more
13d
Zero Hedge
AAPL Is No Longer The "Most Important Stock": Presenting The Top 50 Hedge Fund Longs And ShortsEarlier today we observed that in a world in which central banks have implicitl
AAPL Is No Longer The "Most Important Stock": Presenting The Top 50 Hedge Fund Longs And Shorts
Zero Hedge / Posted 13 days ago
Earlier today we observed that in a world in which central banks have implicitly banned risk with their actions over the past 7 years, hedging long exposure is meaningless (and when central banks do lose control, a few shorts will have zero impact... Read more
13d
News-Medical-Net
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticityAllergan plc (NYSE: AGN), a leading global pharmaceutical company today announc
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
News-Medical-Net / Posted 13 days ago
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX®... Read more
13d
TheStreet.com
Valeant Pays $1B for 'Female Viagra' Maker Sprout PharmaceuticalsValeant noted in its statement that the acquisition of Sprout could serve as a
Valeant Pays $1B for 'Female Viagra' Maker Sprout Pharmaceuticals
TheStreet.com / Posted 13 days ago
Valeant noted in its statement that the acquisition of Sprout could serve as a jumping off point to establish a new portfolio of drugs that uniquely affect women. The acquisition is expected to close in the third quarter of 2015. "I am extremely... Read more
686 related stories
14d
West Side Leader & South Side News Leader
West Side Cause for CelebrationBy Staff WriterBig Brothers Big Sisters of Summit, Medina and Stark Counties M
West Side Cause for Celebration
West Side Leader & South Side News Leader / Posted 14 days ago
By Staff WriterBig Brothers Big Sisters of Summit, Medina and Stark Counties MEDINA — The second annual Ride for Kids’ Sake charity poker run will take place Aug. 23 in Medina and Wayne counties. The event will begin and end at VFW Post 5137 at 3916... Read more
15d
Investopedia
PowerShares Dynamic Pharmaceuticals (PJPPowerShares Dynamic Pharmaceuticals (NYSEARCA: PJP) is an exchange-traded fund
PowerShares Dynamic Pharmaceuticals (PJP
Investopedia / Posted 15 days ago
PowerShares Dynamic Pharmaceuticals (NYSEARCA: PJP) is an exchange-traded fund (ETF) that tracks the investment results of the Dynamic Pharmaceuticals Intellidex Index, which is composed of pharmaceutical companies that are selected using a... Read more
12 related stories
16d
Business Insider
Former gardener asks $75 million for Nixon's 'Western White House'Along with his business partners, Nixon was the historic home's second owner —
Former gardener asks $75 million for Nixon's 'Western White House'
Business Insider / Posted 16 days ago
Along with his business partners, Nixon was the historic home's second owner — he bought it in 1969 for $1.4 million. The current resident, retired Allergan CEO and founder Gavin S. Herbert, is asking $75 million for the Spanish Colonial Revival... Read more
19d
News-Medical-Net
ORBERA Managed Weight Loss System receives final approval from FDAThe ORBERA™ Managed Weight Loss System received its final approval on Wednesday
ORBERA Managed Weight Loss System receives final approval from FDA
News-Medical-Net / Posted 19 days ago
The ORBERA™ Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate... Read more
20d
Orange County Register
Kochs resist an overbearing government holding America backCharles and David Koch recently hosted a meeting in Orange County where they ca
Kochs resist an overbearing government holding America back
Orange County Register / Posted 20 days ago
Charles and David Koch recently hosted a meeting in Orange County where they called on some of America’s leading entrepreneurs to “right injustices that are holding our country back.” Some critics have used this as a new opportunity to question their... Read more
21d
Business Insider
The bond markets are getting stampeded by elephant dealsThis is one of the best years ever for mergers and acquisitions, and Wall Stree
The bond markets are getting stampeded by elephant deals
Business Insider / Posted 21 days ago
This is one of the best years ever for mergers and acquisitions, and Wall Street's biggest firms have been losing market share to tiny upstarts like Centerview Partners and Zaoui & Co. But there's one part of this takeover boom that the boutiques... Read more
21d
PharmaceuticalOnline
Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar”The past few weeks, the generics market has seen several players jump ship and
Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar”
PharmaceuticalOnline / Posted 21 days ago
The past few weeks, the generics market has seen several players jump ship and one company grow significantly — and to some, alarmingly — larger. First to take the plunge was Allergan, which sold off its portfolio of generic drugs to goliath Teva for... Read more
23d
Business Wire
Model N Welcomes Eric Carrasquilla to Executive Team as Senior Vice President, Product ManagementIn his new role, Carrasquilla is responsible for leading product strategy, prod
Model N Welcomes Eric Carrasquilla to Executive Team as Senior Vice President, Product Management
Business Wire / Posted 23 days ago
In his new role, Carrasquilla is responsible for leading product strategy, product management and user experience across Model N’s suite of Revenue Management Cloud applications. “CRM applications have done a remarkable job in automating customer... Read more
23d
Pacific Coast Business Times
Kythera Biopharmaceuticals reports lossWestlake Village-based Kythera Biopharmaceuticals missed analyst estimates when
Kythera Biopharmaceuticals reports loss
Pacific Coast Business Times / Posted 23 days ago
Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2... Read more
24d
Market Watch
Endo International profit, revenue beat estimatesEndo International PLC on Monday reported better-than-expected adjusted earning
Endo International profit, revenue beat estimates
Market Watch / Posted 24 days ago
Endo International PLC on Monday reported better-than-expected adjusted earnings in its second quarter, as the company's sales received a boost from recent acquisitions, though discontinued operations hurt its bottom line. Endo, which relocated to... Read more
More

People in this news